Terms: = Lung cancer AND NT5C2, ENSG00000076685, 22978, P49902, PNT5, NT5B, GMP, cN-II AND Treatment
33 results:
1. [Research progress on the cyclic gmp-AMP synthase stimulator of interferon genes pathway in respiratory diseases].
Qian JH; Ye L; Tan Y
Zhonghua Jie He He Hu Xi Za Zhi; 2024 Mar; 47(3):252-258. PubMed ID: 38448178
[TBL] [Abstract] [Full Text] [Related]
2. Glutathione degradable manganese-doped polydopamine nanoparticles for photothermal therapy and cGAS-STING activated immunotherapy of lung tumor.
Lin H; Jiang C; Wang B; Wang Y; Shangguan Z; Wu Y; Wang X; Huang Y; Wang L; Chen P; Li X; Zhong Z; Wu S
J Colloid Interface Sci; 2024 Jun; 663():167-176. PubMed ID: 38401438
[TBL] [Abstract] [Full Text] [Related]
3. "Spark" PtMnIr Nanozymes for Electrodynamic-Boosted Multienzymatic Tumor Immunotherapy.
Li D; Ha E; Zhou Z; Zhang J; Zhu Y; Ai F; Yan L; He S; Li L; Hu J
Adv Mater; 2024 Mar; 36(13):e2308747. PubMed ID: 38108600
[TBL] [Abstract] [Full Text] [Related]
4. Fungal microbiota sustains lasting immune activation of neutrophils and their progenitors in severe COVID-19.
Kusakabe T; Lin WY; Cheong JG; Singh G; Ravishankar A; Yeung ST; Mesko M; DeCelie MB; Carriche G; Zhao Z; Rand S; Doron I; Putzel GG; Worgall S; Cushing M; Westblade L; Inghirami G; Parkhurst CN; Guo CJ; Schotsaert M; García-Sastre A; Josefowicz SZ; Salvatore M; Iliev ID
Nat Immunol; 2023 Nov; 24(11):1879-1889. PubMed ID: 37872315
[TBL] [Abstract] [Full Text] [Related]
5. Osteoprogenitor-gmp crosstalk underpins solid tumor-induced systemic immunosuppression and persists after tumor removal.
Hao X; Shen Y; Chen N; Zhang W; Valverde E; Wu L; Chan HL; Xu Z; Yu L; Gao Y; Bado I; Michie LN; Rivas CH; Dominguez LB; Aguirre S; Pingel BC; Wu YH; Liu F; Ding Y; Edwards DG; Liu J; Alexander A; Ueno NT; Hsueh PR; Tu CY; Liu LC; Chen SH; Hung MC; Lim B; Zhang XH
Cell Stem Cell; 2023 May; 30(5):648-664.e8. PubMed ID: 37146584
[TBL] [Abstract] [Full Text] [Related]
6. A maladaptive pleural environment suppresses preexisting anti-tumor activity of pleural infiltrating T cells.
Donnenberg VS; Luketich JD; Sultan I; Lister J; Bartlett DL; Ghosh S; Donnenberg AD
Front Immunol; 2023; 14():1157697. PubMed ID: 37063842
[TBL] [Abstract] [Full Text] [Related]
7. An optimized IgG-based B7-H3xCD3 bispecific antibody for treatment of gastrointestinal cancers.
Zekri L; Lutz M; Prakash N; Manz T; Klimovich B; Mueller S; Hoerner S; Hagelstein I; Engel M; Chashchina A; Pfluegler M; Heitmann JS; Jung G; Salih HR
Mol Ther; 2023 Apr; 31(4):1033-1045. PubMed ID: 36793213
[TBL] [Abstract] [Full Text] [Related]
8. cGAS-STING Pathway as the Target of Immunotherapy for lung cancer.
Dan Q; Yang Y; Ge H
Curr Cancer Drug Targets; 2023; 23(5):354-362. PubMed ID: 36380440
[TBL] [Abstract] [Full Text] [Related]
9. MPS1 inhibition primes immunogenicity of KRAS-LKB1 mutant lung cancer.
Kitajima S; Tani T; Springer BF; Campisi M; Osaki T; Haratani K; Chen M; Knelson EH; Mahadevan NR; Ritter J; Yoshida R; Köhler J; Ogino A; Nozawa RS; Sundararaman SK; Thai TC; Homme M; Piel B; Kivlehan S; Obua BN; Purcell C; Yajima M; Barbie TU; Lizotte PH; Jänne PA; Paweletz CP; Gokhale PC; Barbie DA
Cancer Cell; 2022 Oct; 40(10):1128-1144.e8. PubMed ID: 36150391
[TBL] [Abstract] [Full Text] [Related]
10. Human placenta-derived mesenchymal stem cells transplantation in patients with acute respiratory distress syndrome (ARDS) caused by COVID-19 (phase I clinical trial): safety profile assessment.
Aghayan HR; Salimian F; Abedini A; Fattah Ghazi S; Yunesian M; Alavi-Moghadam S; Makarem J; Majidzadeh-A K; Hatamkhani A; Moghri M; Danesh A; Haddad-Marandi MR; Sanati H; Abbasvandi F; Arjmand B; Azimi P; Ghavamzadeh A; Sarrami-Forooshani R
Stem Cell Res Ther; 2022 Jul; 13(1):365. PubMed ID: 35902979
[TBL] [Abstract] [Full Text] [Related]
11. Deciphering the tumor microenvironment cell-infiltrating landscape reveals microenvironment subtypes and therapeutic potentials for nonsquamous NSCLC.
Chen H; Zhang T; Zhang Y; Wu H; Fang Z; Liu Y; Chen Y; Wang Z; Jia S; Ji X; Shang L; Du F; Liu J; Lu M; Chong W
JCI Insight; 2022 Jun; 7(12):. PubMed ID: 35511432
[TBL] [Abstract] [Full Text] [Related]
12. Loss of STING expression is prognostic in non-small cell lung cancer.
Lohinai Z; Dora D; Caldwell C; Rivard CJ; Suda K; Yu H; Rivalland G; Ellison K; Rozeboom L; Dziadziuszko R; Mitchell P; John T; Millan IS; Ren S; Hirsch FR
J Surg Oncol; 2022 May; 125(6):1042-1052. PubMed ID: 35099823
[TBL] [Abstract] [Full Text] [Related]
13. Statins act as transient type I interferon inhibitors to enable the antitumor activity of modified vaccinia Ankara viral vectors.
Tenesaca S; Vasquez M; Alvarez M; Otano I; Fernandez-Sendin M; Di Trani CA; Ardaiz N; Gomar C; Bella A; Aranda F; Medina-Echeverz J; Melero I; Berraondo P
J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34321273
[TBL] [Abstract] [Full Text] [Related]
14. Cytosolic 5'-Nucleotidase II Silencing in lung Tumor Cells Regulates Metabolism through Activation of the p53/AMPK Signaling Pathway.
Pesi R; Allegrini S; Garcia-Gil M; Piazza L; Moschini R; Jordheim LP; Camici M; Tozzi MG
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34209768
[TBL] [Abstract] [Full Text] [Related]
15. Nanoparticle-Mediated Delivery of Inhaled Immunotherapeutics for Treating lung Metastasis.
Jin Q; Zhu W; Zhu J; Zhu J; Shen J; Liu Z; Yang Y; Chen Q
Adv Mater; 2021 Feb; 33(7):e2007557. PubMed ID: 33448035
[TBL] [Abstract] [Full Text] [Related]
16. 4Ei-10 interdiction of oncogenic cap-mediated translation as therapy for non-small cell lung cancer.
Jacobson BA; Ahmad Z; Chen S; Waldusky G; Dillenburg M; Stoian E; Cambron DA; Patel AJ; Patel MR; Wagner CR; Kratzke RA
Invest New Drugs; 2021 Jun; 39(3):636-643. PubMed ID: 33230623
[TBL] [Abstract] [Full Text] [Related]
17. CAR T Cells Redirected to CD44v6 Control Tumor Growth in lung and Ovary Adenocarcinoma Bearing Mice.
Porcellini S; Asperti C; Corna S; Cicoria E; Valtolina V; Stornaiuolo A; Valentinis B; Bordignon C; Traversari C
Front Immunol; 2020; 11():99. PubMed ID: 32117253
[TBL] [Abstract] [Full Text] [Related]
18. STING Pathway Expression Identifies NSCLC With an Immune-Responsive Phenotype.
Della Corte CM; Sen T; Gay CM; Ramkumar K; Diao L; Cardnell RJ; Rodriguez BL; Stewart CA; Papadimitrakopoulou VA; Gibson L; Fradette JJ; Wang Q; Fan Y; Peng DH; Negrao MV; Wistuba II; Fujimoto J; Solis Soto LM; Behrens C; Skoulidis F; Heymach JV; Wang J; Gibbons DL; Byers LA
J Thorac Oncol; 2020 May; 15(5):777-791. PubMed ID: 32068166
[TBL] [Abstract] [Full Text] [Related]
19. Repression of oncogenic cap-mediated translation by 4Ei-10 diminishes proliferation, enhances chemosensitivity and alters expression of malignancy-related proteins in mesothelioma.
Ahmad Z; Jacobson BA; McDonald MW; Vattendahl Vidal N; Vattendahl Vidal G; Chen S; Dillenburg M; Okon AM; Patel MR; Wagner CR; Kratzke RA
Cancer Chemother Pharmacol; 2020 Feb; 85(2):425-432. PubMed ID: 31974652
[TBL] [Abstract] [Full Text] [Related]
20. Activation of cGAS-dependent antiviral responses by DNA intercalating agents.
Pépin G; Nejad C; Thomas BJ; Ferrand J; McArthur K; Bardin PG; Williams BR; Gantier MP
Nucleic Acids Res; 2017 Jan; 45(1):198-205. PubMed ID: 27694309
[TBL] [Abstract] [Full Text] [Related]
[Next]
